Orange Book product · Brand (NDA)

BORTEZOMIB

Brand (NDA)NDA 205004DISCN FRESENIUS KABI USA

Nov 06, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Nov 06, 2017
8 yr 9 mo ago
Today
Patent 8962572 expires
Listed drug product patent expiration.
Nov 03, 2032
in 6 yr 6 mo

Active ingredient

BORTEZOMIB

Strength

3.5MG/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 205004

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Reference standard (RS)

Active-ingredient family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8962572	Nov 03, 2032	in 6 yr 6 mo	Product